Pipex heads to American Stock Exchange, about to license 2 drugs
Ann Arbor-based Pipex Pharmaceutical Inc. has moved to the American Stock Exchange and will launch two drugs — one to treat multiple sclerosis and another to treat the lung-crippling Wilson’s disease. a
Ann Arbor-based Pipex Pharmaceutical Inc. has moved to the American Stock Exchange and will launch two drugs — one to treat multiple sclerosis and another to treat the lung-crippling Wilson’s disease. a
Excerpt:
Pipex was founded in Miami in 2001 by Steve Kanzer, the company’s chairman and CEO. A biotech investor, Kanzer moved Pipex to Michigan in 2004 to be nearer to the talent pool in Ann Arbor.
“Florida is working on its biotech industry. But there is so much more talent in Michigan, I decided to come here,” he said.
Read the entire article here.
Related Articles
An Oakland County nonprofit is brewing success for immigrant entrepreneurs
Immigrant business owners and entrepreneurs can help revitalize and sustain Michigan’s economy.
On-Demand Coaching helps Michigan municipalities and their small businesses build a winning team
Program helps municipalities connect small businesses and entrepreneurs with existing capital and technical assistance.
Partner Partner Content How employee retention grows Michigan’s health care workforce
Retaining folks working within the health care sector is a vital strategy in turning around current and projected workforce shortages.
